Pharmacovigilance Committee

Pharmacovigilance Committee

Pharmacovigilance refers to the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions and other drug-related problems. At Dhanalakshmi Srinivasan Institute of Medical Sciences and Hospital, the Pharmacovigilance Committee functions to promote patient safety and rational use of medicines, in alignment with pharmacovigilance committee medical college.The committee operates in accordance with the Pharmacovigilance Programme of India (PvPI), a national initiative under the Central Drugs Standard Control Organisation (CDSCO), coordinated by the Indian Pharmacopoeia Commission (IPC), Ghaziabad.

Purpose and Regulatory Mandate

As per the regulations of the Medical Council of India and the National Medical Commission, it is mandatory for every medical college to constitute a Pharmacovigilance Committee. The committee is responsible for monitoring, evaluating, and reporting adverse drug reactions occurring in patients receiving care at the institution, thereby contributing to PvPI adverse drug reaction reporting.

Goals and Objectives

The key objectives of the Pharmacovigilance Committee are to:

  • Create awareness about adverse drug reactions among healthcare professionals and students
  • Identify, document, and report ADRs to appropriate national authorities
  • Perform causality assessment of reported ADRs
  • Undertake pharmacovigilance-related research activities
  • Strengthen participation in the National Pharmacovigilance Programme

These activities support improved patient outcomes and drug safety monitoring in hospitals.

Scope and Functions

The committee plans, implements, and monitors pharmacovigilance activities across the institution and meets periodically (once every two to three months). Its functions include regular visits to OPD and IPD areas, ensuring availability of ADR reporting forms, collecting complete ADR data, performing expert evaluation, and forwarding validated reports to PvPI, ensuring an effective institutional pharmacovigilance programme.

Roles and Responsibilities

The Chairman and Coordinator oversee committee functioning and administrative activities. Members function as subject experts and facilitators by sensitising healthcare staff, educating patients, collecting ADR data, conducting causality assessments, and ensuring timely submission of reports to national authorities, strengthening the ADR reporting system hospital.

Pharmacovigilance Committee – Members List

S. No

Name

Designation

Post

Contact No

1

Dr. Visvanathan V

Dean

Chairman

7094466469

2

Dr. Vijayalakshmi M

Medical Superintendent

Co-Chairman

9524540312

3

Dr. Revathi P

Professor & Head, Pharmacology

Convener

9786266905

4

Dr. Sowmini K

Assistant Professor, Pharmacology

Member Secretary

9790259678

5

Dr. Velarul S

Assistant Professor, Pharmacology

Nodal Officer

9790618801

6

Dr. N. Prasanna

Professor & Head, General Medicine

Member

9448088010

7

Dr. Anne Madhu Bindu

Professor & Head, OBG

Member

9849224078

8

Dr. Pugalenthi V

Professor & Head, Orthopaedics

Member

9443725840

9

Dr. Senthil Kumar A L

Professor & Head, Dermatology

Member

9700757564

10

Dr. Paramasivan A

Professor & Head, Anaesthesiology

Member

9443677277

11

Dr. Ramaraju Mudunuri N.V.S.M.S

Professor & Head, General Surgery

Member

9505532999

12

Dr. Sugaparaneetharan A

Associate Professor, Psychiatry

Member

9894356572

13

Dr. Chitra B

Associate Professor, Community Medicine

Member

8124932475

14

Mr. Sivagurunathan

Chief Pharmacist

Member

9080959010

15

Dr. Mohana

Nursing Superintendent

Member

7539966126

Commitment to Patient Safety

Through structured monitoring, transparent reporting, and continuous review, the Pharmacovigilance Committee reinforces safe medication practices and strengthens patient trust in healthcare delivery. At Dhanalakshmi Srinivasan Institute of Medical Sciences and Hospital, the committee plays a vital role in promoting responsible medicine use and continuous quality improvement through pharmacovigilance in healthcare institutions.